Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Biomarker combinations from different modalities predict early disability accumulation in multiple sclerosis

31 Jan 2025

Abstract excerpt

Objective: Establishing biomarkers to predict multiple sclerosis (MS) disability accrual has been challenging using a single biomarker approach, likely due to the complex interplay of neuroinflammation and neurodegeneration. Here, we aimed to investigate the prognostic value of single and multimodal biomarker combinations to predict four-year disability progression in patients with MS. Methods: In total, 111 MS...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Glioma Diagnosis and Treatment
Share to Multiple Sclerosis Research Studies
Share to Neuroinflammation and Neurodegeneration Mechanisms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 39958357
DOI: 10.3389/fimmu.2025.1532660

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Biomarker combinations from different modalities predict early disability accumulation in multiple sclerosisPMID 39958357Read ↗

Biomarkers of Progression Independent of Relapse Activity—Can We Actually Measure It Yet?Semantic proximity Read ↗

Inflammatory and neurodegenerative serum protein biomarkers increase sensitivity to detect disease activity in multiple sclerosisSemantic proximity Read ↗

Association between serum multi-protein biomarker profile and real-world disability in multiple sclerosisSemantic proximity Read ↗

Molecular mechanisms associated with multiple sclerosis progression, severity and phenotypeSemantic proximity Read ↗

Current status and future opportunities in modeling Multiple Sclerosis clinical characteristicsSemantic proximity Read ↗

Multimodal predictors of disability progression and processing speed decline in relapsing-remitting multiple sclerosisSemantic proximity Read ↗

Association of magnetic resonance imaging phenotypes and serum biomarker levels with treatment response and long-term disease outcomes in multiple sclerosis patients.Semantic proximity Read ↗

Decoding disease burden in multiple sclerosis: The role of IL-10 as biomarker of neuroinflammation and neurodegenerationSemantic proximity Read ↗

Combining CSF and Serum Biomarkers to Differentiate Mechanisms of Disability Worsening in Multiple SclerosisSemantic proximity Read ↗

Development of biomarkers in multiple sclerosis.Semantic proximity Read ↗

Longitudinal high-frequency blood biomarkers of axonal injury and astrocytic activation after immune reconstitution in multiple sclerosisSemantic proximity Read ↗

Increased Disability Progression in rs10191329AA Carriers with Multiple Sclerosis Is Preceded by Neurofilament Light Chain Elevations.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.